[fcb5af]: / literature / by_gene_clean / SOCS1.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 33297669 10.3324/haematol.2020.267294 2022 Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas. SOCS1
2 34265801 10.1097/PAS.0000000000001780 2022 Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of Transdifferentiation. SOCS1
3 34714908 10.1182/bloodadvances.2021005486 2022 Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways. SOCS1
4 34791836 10.1002/cam4.4422 2022 Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial. SOCS1
5 35075971 10.1080/10428194.2021.2010060 2022 Circulating tumor DNA in primary mediastinal large B-cell lymphoma versus classical Hodgkin lymphoma: a retrospective study. SOCS1
6 35205765 10.3390/cancers14041018 2022 Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study. SOCS1
7 35240014 10.4143/crt.2022.017 2022 Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas. SOCS1
8 35600392 10.3389/fonc.2022.881801 2022 SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer. SOCS1
9 35879731 10.1186/s40364-022-00401-4 2022 Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma. SOCS1
10 35885481 10.3390/diagnostics12071575 2022 Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma. SOCS1
11 32079702 10.3324/haematol.2019.237719 2021 Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study. SOCS1
12 32961552 10.1182/blood.2020007507 2021 Mutational landscape of gray zone lymphoma. SOCS1
13 33684939 10.1182/blood.2020007683 2021 Characterization of DLBCL with a PMBL gene expression signature. SOCS1
14 33899787 10.1097/PAS.0000000000001691 2021 The Positivity of Phosphorylated STAT3 Is a Novel Marker for Favorable Prognosis in Germinal Center B-Cell Type of Diffuse Large B-Cell Lymphoma. SOCS1
15 33951889 10.3324/haematol.2020.271957 2021 MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma. SOCS1
16 34039950 10.1038/s41408-021-00493-5 2021 Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing. SOCS1
17 34272731 10.1111/bjh.17708 2021 EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features. SOCS1
18 34312841 10.1111/bjh.17719 2021 Liquid biopsy: a non-invasive approach for Hodgkin lymphoma genotyping. SOCS1
19 34405005 10.7150/jca.60390 2021 Serial surveillance by circulating tumor DNA profiling after chimeric antigen receptor T therapy for the guidance of r/r diffuse large B cell lymphoma precise treatment. SOCS1
20 34925435 10.3389/fgene.2021.677650 2021 Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing. SOCS1
21 31738823 10.1182/blood.2019002699 2020 Distinct molecular profile of IRF4-rearranged large B-cell lymphoma. SOCS1
22 31774495 10.1182/blood.2019001904 2020 Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL. SOCS1
23 32239385 10.1007/s11523-020-00710-4 2020 Genomic Alterations and MYD88<sup>MUT</sup> Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib. SOCS1
24 32555149 10.1038/s41408-020-0335-0 2020 CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma. SOCS1
25 32947237 10.1016/j.tranon.2020.100855 2020 Identification of clinical molecular targets for childhood Burkitt lymphoma. SOCS1
26 33045225 10.1016/j.humpath.2020.09.014 2020 The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma. SOCS1
27 30211726 10.1097/PAS.0000000000001154 2019 Cyclin D1-positive Mediastinal Large B-Cell Lymphoma With Copy Number Gains of CCND1 Gene: A Study of 3 Cases With Nonmediastinal Disease. SOCS1
28 30213827 10.3324/haematol.2018.203224 2019 <i>JUNB</i>, <i>DUSP2</i>, <i>SGK1</i>, <i>SOCS1</i> and <i>CREBBP</i> are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma. SOCS1
29 31305266 10.1097/PAS.0000000000001324 2019 Chronic Active Epstein-Barr Virus Infection of T/NK-Cell Type Mimicking Classic Hodgkin Lymphoma: Clinicopathologic and Genetic Features of 8 Cases Supporting a Variant With Hodgkin/Reed-Sternberg-like Cells of NK Phenotype. SOCS1
30 29650799 10.1182/blood-2017-11-814913 2018 Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma. SOCS1
31 30054295 10.1182/blood-2018-01-829424 2018 Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma. SOCS1
32 30087457 10.1038/s41374-018-0096-6 2018 Novel cell enrichment technique for robust genetic analysis of archival classical Hodgkin lymphoma tissues. SOCS1
33 28302137 10.1186/s13045-017-0438-7 2017 Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort. SOCS1
34 27198204 10.1038/leu.2016.135 2016 Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis. SOCS1
35 26599546 10.1371/journal.pone.0139663 2015 Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines. SOCS1
36 22387553 10.4049/jimmunol.1102899 2012 Downregulation of inflammatory microRNAs by Ig-like transcript 3 is essential for the differentiation of human CD8(+) T suppressor cells. SOCS1
37 10856136 10.1067/mai.2000.107604 2000 IL-4/IL-13 signaling beyond JAK/STAT. SOCS1